Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like allergy drugs to fight it.

No one has to fight blood cancer alone and advocates are working to bring light to the darkness of cancer. WSAV spoke to ...

Nothing could have prepared me for the pain, isolation and loss that cancer brings, but it has also been a transformative experience.

Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21SIDNEY is an ongoing Phase 2 trial of EO2463 in 48 indolent Non-Hodgkin Lymphoma (iNHL) patientsEnterome ...

The Nazareth senior was diagnosed with Hodgkin lymphoma in March, and is pushing through despite the challenges.

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) ...

June is Cancer Survivor Day. One hospital group is celebrating those who beat the disease to bring awareness to the strength ...